首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1508741

苯二氮平类药物市场：副产品、给药途径、应用、通路与地区

Benzodiazepine Drugs Market, By Product (Long Acting Benzodiazepines and Short Acting Benzodiazepines), By Route of Administration, By Application, By Distribution Channel, By Geography

出版日期: 2024年05月30日 | 出版商:

Coherent Market Insights | 英文 208 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计2024年苯二氮平类药物的全球市场规模为32.274亿美元，预计2031年将达到41.995亿美元，2024年至2031年复合年增长率为3.8%。

图 1. 苯二氮平类药物市场占有率(%)，依地区划分，2024 年

由于主要国家焦虑和睡眠障碍盛行率上升，苯二氮平类药物的全球市场正在显着成长。苯二氮平类药物是一类促效剂，用于治疗失眠、焦虑、烦躁、癫痫发作、恐慌发作和肌肉痉挛等疾病，因为它们对中枢神经系统有影响。这些药物可作为中枢神经系统抑制剂，抑制大脑异常兴奋，同时诱导镇静。苯二氮平类药物可增强 GABAA 受体的作用，进而调节睡眠、焦虑和肌肉张力。此外，苯二氮平类药物广泛用于短期治疗焦虑和睡眠障碍，以及缓解酒精戒断症状。

市场动态：

生活方式的改变和压力水平的增加正在增加整体焦虑症和失眠等疾病的盛行率，全球对苯二氮平类药物的需求预计将增加。根据世界卫生组织发布的报告，全球约有2.64亿人患有忧郁症和焦虑症。根据美国焦虑和忧郁症协会的数据，超过 38% 的美国人有焦虑症状。越来越多地采用苯二氮平类药物来治疗心理健康问题的症状，这可能会推动全球苯二氮平类药物市场的成长。然而，诸如对长期使用苯二氮平类药物相关副作用（如嗜睡、头晕、协调性和记忆力下降）的担忧等因素可能会给市场相关人员带来挑战。此外，替代疗法的可用性也可能阻碍预测期内的市场成长。另一方面，药物开发的进步引入了更安全、副作用更少的苯二氮平类药物，为不久的将来市场成长提供了重大机会。

本研究的主要特点

该报告对全球苯二氮平类药物市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031年）的市场规模（百万美元）和年复合成长率（CAGR%）。
它还揭示了各个细分市场的潜在收益成长机会，并说明了该市场有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
根据公司亮点、产品系列、主要亮点、绩效和策略等参数，对全球苯二氮平类市场的主要企业进行概况分析。
所列的主要公司包括Torrent Pharmaceuticals Ltd.、Mallinckrodt Pharmaceuticals、Pfizer Inc.、Viatris (Mylan NV)、Labiana Pharmaceuticals、Bausch Health Companies, Inc.、Teva Pharmaceutical Industries Ltd.、Amneal Pharmaceuticals LLC、Sunnya Pharmaceticalseva Pharmaceutical Industriesu.、Amneal Pharmaceuticals LLC、Sunnya Pharmaceticalseva Pharmaceutical Ltd.。 UK Ltd. 、Lupin 和 Hikma Pharmaceuticals PLC。
该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
苯二氮平类药物的全球市场迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员可以透过用于全球苯二氮平类市场分析的各种策略矩阵来促进他们的决策。

公司简介
- Torrent Pharmaceuticals Ltd.
- Mallinckrodt Pharmaceuticals
- Pfizer Inc.
- Viatris（Mylan NV）
- Labiana Pharmaceuticals
- Bausch Health Companies, Inc.
- Teva Pharmaceutical Industries Ltd.
- Amneal Pharmaceuticals LLC
- Sun Pharmaceutical Industries Ltd.
- Aurobindo Pharma
- Par Pharmaceutical
- Intas Pharmaceuticals Ltd.
- Neurelis, Inc.
- Almatica Pharma LLC
- Aquestive Therapeutics, Inc.
- F.Hoffmann-La Roche Ltd.
- Wockhardt UK Ltd
- Lupin
- Hikma Pharmaceuticals PLC

第十一章分析师建议

升起和降落
综合机会图

第十二章参考文献与调查方法

参考
调查方法

简介目录

Product Code: CMI5001

Global benzodiazepine drugs market is estimated to be valued at USD 3,227.4 Mn in 2024 and is expected to reach USD 4,199.5 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 3.8% from 2024 to 2031.

Figure 1. Benzodiazepine Drugs Market Share (%), By Region, 2024

Global benzodiazepine drugs market has been witnessing significant growth due to rising prevalence of anxiety and sleep disorders across major countries. Benzodiazepines are a class of psychoactive drugs that are prescribed to treat conditions such as insomnia, anxiety, agitation, seizures, panic attacks and muscle spasms by their effect on the central nervous system. These act as central nervous system depressants, reducing abnormal excitement in the brain, while inducing sedation. Benzodiazepines enhance the effect of the GABAA receptors, which are responsible to regulating aspects of sleep, anxiety and muscle tension. Moreover, benzodiazepines are widely prescribed for short term management of anxiety and sleep disorders along with symptomatic relief of alcohol withdrawal.

Market Dynamics:

Growing prevalence of conditions like generalized anxiety disorder and insomnia due to changing lifestyle and increasing stress levels is expected to boost demand for benzodiazepine drugs globally. According to the report published by WHO, around 264 million people suffer from depression and anxiety worldwide. More than 38% of Americans had experience symptoms of anxiety, according to the Anxiety and Depression Association of America. Increasing adoption of benzodiazepines to manage symptoms of mental health issues can drive the global benzodiazepine drugs market growth. However, factors such as concerns regarding side effects associated with long term use of benzodiazepines including drowsiness, dizziness, and impaired coordination and memory can pose a challenge for market players. Moreover, availability of alternative treatments can hamper the market growth over the forecast period. Meanwhile, advancements in drug development to introduce safer variants of benzodiazepines with fewer side effects present significant opportunities for the market growth in the near future.

Key Features of the Study:

This report provides an in-depth analysis of the global benzodiazepine drugs market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global benzodiazepine drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this includes Torrent Pharmaceuticals Ltd., Mallinckrodt Pharmaceuticals, Pfizer Inc., Viatris (Mylan N.V.), Labiana Pharmaceuticals, Bausch Health Companies, Inc., Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Par Pharmaceutical, Intas Pharmaceuticals Ltd., Neurelis, Inc., Almatica Pharma LLC, Aquestive Therapeutics, Inc., F.Hoffmann-La Roche Ltd., Wockhardt UK Ltd, Lupin, Hikma Pharmaceuticals PLC
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global benzodiazepine drugs market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global benzodiazepine drugs market

Detailed Segmentation

By Product:
- Long Acting Benzodiazepines
- Chlordiazepoxide
- Diazepam
- Lorazepam
- Alprazolam
- Clonazepam
- Others
- Short Acting Benzodiazepines
- Temazepam
- Midazolam
- Triazolam
- Others
By Route of Administration:
- Oral
- Injectables
- Others
By Application:
- Anxiety Disorders
- Nervousness
- Sedation
- Seizures
- Alcohol Withdrawal
- Others
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Torrent Pharmaceuticals Ltd.
- Mallinckrodt Pharmaceuticals
- Pfizer Inc.
- Viatris (Mylan N.V.)
- Labiana Pharmaceuticals
- Bausch Health Companies, Inc.
- Teva Pharmaceutical Industries Ltd.
- Amneal Pharmaceuticals LLC
- Sun Pharmaceutical Industries Ltd.
- Aurobindo Pharma
- Par Pharmaceutical
- Intas Pharmaceuticals Ltd.
- Neurelis, Inc.
- Almatica Pharma LLC
- Aquestive Therapeutics, Inc.
- Hoffmann-La Roche Ltd.
- Wockhardt UK Ltd
- Lupin
- Hikma Pharmaceuticals PLC

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Route of Administration
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Manufacturer Revenue
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Benzodiazepine Drugs Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Benzodiazepine Drugs Market, By Product, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Long Acting Benzodiazepines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Chlordiazepoxide
Diazepam
Lorazepam
Alprazolam
Clonazepam
Others
Short Acting Benzodiazepines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Temazepam
Midazolam
Triazolam
Others

6. Global Benzodiazepine Drugs Market, By Route of Administration, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Injectables
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global Benzodiazepine Drugs Market, By Application, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Anxiety Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Nervousness
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Sedation
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Seizures
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Alcohol Withdrawal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

8. Global Benzodiazepine Drugs Market, By Distribution Channel, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

9. Global Benzodiazepine Drugs Market, By Region, 2019 - 2031, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Mn)
  - North Africa
  - Central Africa
  - South Africa

10. Competitive Landscape

Company Profiles
- Torrent Pharmaceuticals Ltd.*
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Mallinckrodt Pharmaceuticals
- Pfizer Inc.
- Viatris (Mylan N.V.)
- Labiana Pharmaceuticals
- Bausch Health Companies, Inc.
- Teva Pharmaceutical Industries Ltd.
- Amneal Pharmaceuticals LLC
- Sun Pharmaceutical Industries Ltd.
- Aurobindo Pharma
- Par Pharmaceutical
- Intas Pharmaceuticals Ltd.
- Neurelis, Inc.
- Almatica Pharma LLC
- Aquestive Therapeutics, Inc.
- F.Hoffmann-La Roche Ltd.
- Wockhardt UK Ltd
- Lupin
- Hikma Pharmaceuticals PLC

11. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

12. References and Research Methodology

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

苯二氮平类药物市场：副产品、给药途径、应用、通路与地区